全文获取类型
收费全文 | 1640702篇 |
免费 | 113422篇 |
国内免费 | 2559篇 |
专业分类
耳鼻咽喉 | 22712篇 |
儿科学 | 53331篇 |
妇产科学 | 43175篇 |
基础医学 | 242897篇 |
口腔科学 | 46101篇 |
临床医学 | 147943篇 |
内科学 | 309096篇 |
皮肤病学 | 37444篇 |
神经病学 | 121660篇 |
特种医学 | 63287篇 |
外国民族医学 | 276篇 |
外科学 | 246579篇 |
综合类 | 33860篇 |
现状与发展 | 3篇 |
一般理论 | 404篇 |
预防医学 | 117943篇 |
眼科学 | 38339篇 |
药学 | 129297篇 |
10篇 | |
中国医学 | 4709篇 |
肿瘤学 | 97617篇 |
出版年
2019年 | 12232篇 |
2018年 | 17624篇 |
2017年 | 13786篇 |
2016年 | 15498篇 |
2015年 | 17279篇 |
2014年 | 23593篇 |
2013年 | 34942篇 |
2012年 | 47292篇 |
2011年 | 49928篇 |
2010年 | 29356篇 |
2009年 | 27642篇 |
2008年 | 46230篇 |
2007年 | 49603篇 |
2006年 | 50483篇 |
2005年 | 47641篇 |
2004年 | 46000篇 |
2003年 | 44070篇 |
2002年 | 42654篇 |
2001年 | 86431篇 |
2000年 | 88328篇 |
1999年 | 73428篇 |
1998年 | 18770篇 |
1997年 | 16324篇 |
1996年 | 16517篇 |
1995年 | 15627篇 |
1994年 | 14186篇 |
1993年 | 13362篇 |
1992年 | 55336篇 |
1991年 | 54058篇 |
1990年 | 52996篇 |
1989年 | 51419篇 |
1988年 | 46514篇 |
1987年 | 45272篇 |
1986年 | 42868篇 |
1985年 | 40213篇 |
1984年 | 29372篇 |
1983年 | 24846篇 |
1982年 | 13762篇 |
1979年 | 26563篇 |
1978年 | 18242篇 |
1977年 | 15952篇 |
1976年 | 14403篇 |
1975年 | 16282篇 |
1974年 | 18970篇 |
1973年 | 18291篇 |
1972年 | 17383篇 |
1971年 | 16272篇 |
1970年 | 15234篇 |
1969年 | 14444篇 |
1968年 | 12972篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
IntroductionHip displacement is common in cerebral palsy (CP) and is related to the severity of neurological and functional impairment. It is a silent, but progressive disease, and can result in significant morbidity and decreased quality of life, if left untreated. The pathophysiology of hip displacement in CP is a combination of hip flexor-adductor muscle spasticity, abductor muscle weakness, and delayed weight-bearing, resulting in proximal femoral deformities and progressive acetabular dysplasia. Due to a lack of symptoms in the early stages of hip displacement, the diagnosis is easily missed. Awareness of this condition and regular surveillance by clinical examination and serial radiographs of the hips are the key to early diagnosis and treatment.Hip surveillance programmesSeveral population-based studies from around the world have demonstrated that universal hip surveillance in children with CP allows early detection of hip displacement and appropriate early intervention, with a resultant decrease in painful dislocations. Global hip surveillance models are based upon the patients’ age, functional level determined by the Gross Motor Function Classification system (GMFCS), gait classification, standardized clinical exam, and radiographic indices such as the migration percentage (MP), as critical indicators of progressive hip displacement.ConclusionDespite 25 years of evidence showing the efficacy of established hip surveillance programmes, there is poor awareness among healthcare professionals in India about the importance of regular hip surveillance in children with CP. There is a need for professional organizations to develop evidence-based guidelines for hip surveillance which are relevant to the Indian context. 相似文献
12.
13.
14.
15.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
16.
Comprehensive evidence regarding the treatment of non-anaemic iron deficiency in patients undergoing valvular heart surgery is lacking. This study aimed to investigate the association between non-anaemic iron deficiency and postoperative outcomes in these patients. We retrospectively analysed 321 patients of which 180 (56%) had iron deficiency (defined as serum ferritin < 100 ng.ml-1 or < 300 ng.ml-1 with transferrin saturation < 20%). While the iron-deficient group had lower pre-operative haemoglobin levels than the non-iron deficient group (median (IQR [range]) 134 (127–141 [120–172]) g.l-1, 143 (133–150 [120–179]) g.l-1, p = 0.001), there was no between-group difference in allogeneic red blood cell transfusion. Median (IQR [range]) days alive and out of hospital at postoperative day 90 was 1 day shorter in the iron-deficient group (80 (77–82 [9–85]) days vs. 81 (79–83 [0–85]) days, p = 0.026). In multivariable analysis, only cardiopulmonary bypass duration (p = 0.032) and intra-operative allogeneic red blood cell transfusion (p = 0.011) were significantly associated with reduced days alive and out of hospital at postoperative day 90. Iron deficiency did not exert any adverse influence on secondary outcomes except length of hospital stay. Our findings indicate that non-anaemic iron deficiency alone is not associated with adverse effects in patients undergoing valvular heart surgery when it does not translate into an increased risk of allogeneic transfusion. 相似文献
17.
18.
Malunguja Gisandu K. Devi Ashalata 《Proceedings of the National Academy of Sciences, India. Section B.》2022,92(1):105-120
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences - Heavy metal concentrations in surface soils of Reserved Forests (RFs) have a significant impact on... 相似文献
19.
Purnima Gogoi Geetika Kaur Nikhlesh K Singh 《World journal of gastroenterology : WJG》2022,28(46):6497-6511
Colorectal cancer (CRC) is the third most diagnosed cancer and the second leading cause of cancer-related mortality in the United States. Across the globe, people in the age group older than 50 are at a higher risk of CRC. Genetic and environmental risk factors play a significant role in the development of CRC. If detected early, CRC is preventable and treatable. Currently, available screening methods and therapies for CRC treatment reduce the incidence rate among the population, but the micrometastasis of cancer may lead to recurrence. Therefore, the challenge is to develop an alternative therapy to overcome this complication. Nanotechnology plays a vital role in cancer treatment and offers targeted chemotherapies directly and selectively to cancer cells, with enhanced therapeutic efficacy. Additionally, nanotechnology elevates the chances of patient survival in comparison to traditional chemotherapies. The potential of nanoparticles includes that they may be used simultaneously for diagnosis and treatment. These exciting properties of nanoparticles have enticed researchers worldwide to unveil their use in early CRC detection and as effective treatment. This review discusses contemporary methods of CRC screening and therapies for CRC treatment, while the primary focus is on the theranostic approach of nanotechnology in CRC treatment and its prospects. In addition, this review aims to provide knowledge on the advancement of nanotechnology in CRC and as a starting point for researchers to think about new therapeutic approaches using nanotechnology. 相似文献
20.